Time to recurrence in neovascular age-related macular degeneration after ranibizumab treatment: baseline characteristics of treatment-naive patients enrolled in the ORACLE study

被引：0
|
作者：
Devin, Francois [1 ]
Fourmaux, Eric [2 ]
Quentel, Gabriel [3 ]
Uzzan, Joel [4 ]
Quaranta El-Maftouhi, Maddalena [5 ]
Francais-Maury, Catherine [6 ]
Roquet, Wilfried [7 ]
Castelnovo, Laurent [8 ]
Razavi, Sam [9 ]
Finzi, Laetitia [10 ]
机构：
[1] Ctr Monticelli Paradis, Ophtalmol, Marseille, France
[2] Palais Galien, Ophtalmol, Bordeaux, France
[3] Ctr Imagerie & Laser, Paris, France
[4] Clin Mathilde, Ophtalmol, Rouen, France
[5] Ctr Rabelais, Ophtalmol, Lyon, France
[6] Ctr Odeon, Ophtalmol, Paris, France
[7] Ctr Blatin, Ophtalmol, Clermont Ferrand, France
[8] Clin Maison Rouge, Ophtalmol, Strasbourg, France
[9] Clin St Gatien, Ophtalmol, Tours, France
[10] Novartis Pharma SAS, Retine, Rueil Malmaison, France
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2016年 / 57卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
3353
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Quantitative subanalysis of optical coherence tomography after treatment with ranibizumab for neovascular age-related macular degeneration
    Keane, Pearse A.
    Liakopoulos, Sandra
    Ongchin, Sharel C.
    Heussen, Florian M.
    Msutta, Sandeep
    Chang, Karen T.
    Walsh, Alexander C.
    Sadda, Srinivas R.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2008, 49 (07) : 3115 - 3120
  • [42] Fixed Regimen Treatment in Unselected Naive Patients Cohort with Neovascular Age-Related Macular Degeneration
    Casaroli-Marano, Ricardo P.
    Bernal-Morales, Carolina
    Chamorro-Lopez, Lillian
    Dotti-Boada, Marina
    Figueroa-Vercellino, Juan P.
    Alforja, Socorro
    [J]. JOURNAL OF OPHTHALMOLOGY, 2020, 2020
  • [43] COMPARISON OF INTRAVITREAL BEVACIZUMAB FOLLOWED BY RANIBIZUMAB FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Stepien, Kimberly E.
    Rosenfeld, Philip J.
    Puliafito, Carmen A.
    Feuer, William
    Shi, Wei
    Al-Attar, Luma
    Dubovy, Sander R.
    Murray, Timothy G.
    Davis, Janet L.
    Lee, Wen-Hsiang
    Schwartz, Stephen G.
    Smiddy, William E.
    Berrocal, Audina M.
    Flynn, Harry W., Jr.
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2009, 29 (08): : 1067 - 1073
  • [44] PROGNOSTIC FACTORS AND OUTCOME OF INTRAVITREAL RANIBIZUMAB TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Narayan, Daniel
    Meucke, James
    [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2012, 40 : 113 - 113
  • [45] Comparative Review of Ranibizumab versus Bevacizumab in the Treatment of Neovascular Age-related Macular Degeneration
    Heroman, J. Wesley
    Kaplan, Henry J.
    [J]. CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2010, 2 : 491 - 497
  • [46] Evaluation of Port Delivery System with ranibizumab for the treatment of neovascular age-related macular degeneration
    Patel, Annika J.
    Pieramici, Dante J.
    Bagheri, Nika
    [J]. THERAPEUTIC DELIVERY, 2021, 12 (03) : 191 - 200
  • [47] LONG-TERM EFFICACY OF RANIBIZUMAB FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Chang, Andrew A.
    Chew, Jamie
    Syed, Adil
    Joachim, Nichole
    Li, Haitao
    Broadhead, Geoffrey K.
    Zhu, Meidong
    [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 41 : 98 - 98
  • [48] One-year outcomes with ranibizumab in treatment naive patients with neovascular age-related macular degeneration: an interim analysis from the LUMINOUS™ study
    Brand, Christopher
    Lacey, Sue
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [49] Treatment of neovascular age-related macular degeneration with pegaptanib and boosting with bevacizumab or ranibizumab as needed
    Farah, Samer E.
    [J]. OPHTHALMIC SURGERY LASERS & IMAGING, 2008, 39 (04) : 294 - 298
  • [50] Treatment of recurrent neovascular age-related macular degeneration with ranibizumab according to the PrONTO scheme
    Wolf, A.
    Reznicek, L.
    Muhr, J.
    Ulbig, M.
    Kampik, A.
    Haritoglou, C.
    [J]. OPHTHALMOLOGE, 2013, 110 (08): : 740 - 745
12345